Filing Details
- Accession Number:
- 0001193125-23-034064
- Form Type:
- 13G Filing
- Publication Date:
- 2023-02-12 19:00:00
- Filed By:
- Cmb International Capital Corp Ltd
- Company:
- Burning Rock Biotech Limited (NASDAQ:BNR)
- Filing Date:
- 2023-02-13
- SEC Url:
- 13G Filing
Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.
| Name | Sole Voting Power | Shared Voting Power | Sole Dispositive Power | Shared Dispositive Power | Aggregate Amount Owned Power | Percent of Class |
|---|---|---|---|---|---|---|
| China Merchants Bank Co., Limited | 7,017,385 | 7,017,385 | 7,017,385 | 8.0% | ||
| CMB International Capital Holdings Corporation Limited | 7,017,385 | 7,017,385 | 7,017,385 | 8.0% | ||
| CMB International Capital Corporation Limited | 7,017,385 | 7,017,385 | 7,017,385 | 8.0% | ||
| CMB International Investment Management Limited | 7,017,385 | 7,017,385 | 7,017,385 | 8.0% | ||
| CMB International Private Investment Limited | 7,017,385 | 7,017,385 | 7,017,385 | 8.0% | ||
| EverGreen SeriesC Limited Partnership | 5,964,435 | 5,964,435 | 5,964,435 | 6.8% | ||
| CMBI Private Equity Series SPC on behalf of and for the account of Biotechnology Fund IV SP | 1,052,950 | 1,052,950 | 1,052,950 | 1.2% |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. 2)*
Burning Rock Biotech Limited
(Name of Issuer)
Class A Ordinary Shares, par value US$0.0002 per share
(Titles of Class of Securities)
G17173 108**
(CUSIP Number)
December 31, 2022
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
☐ Rule 13d-1(b)
☐ Rule 13d-1(c)
☒ Rule 13d-1(d)
| * | The remainder of this cover page shall be filled out of a reporting persons initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. |
The information required in the remainder of this cover page shall not be deemed to be filed for the purpose of Section 18 of the Securities Exchange Act of 1934, as amended (the Act) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
| ** | This CUSIP number applies to the Class A ordinary shares (Class A Ordinary Shares) of Burning Rock Biotech Limited (the Issuer). CUSIP number 12233L 107 applies to the American Depositary Shares (ADSs) of the Issuer, each ADS representing one Class A Ordinary Share. |
| CUSIP No. G17173 108 | 13G | Page 2 of 14 |
| 1 | NAME OF REPORTING PERSON
China Merchants Bank Co., Limited | |||||
| 2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ☐ (b) ☐
| |||||
| 3 | SEC USE ONLY
| |||||
| 4 | CITIZENSHIP OR PLACE OF ORGANIZATION
Hong Kong | |||||
| NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH: | 5 | SOLE VOTING POWER
- 0 - | ||||
| 6 | SHARED VOTING POWER
7,017,385 | |||||
| 7 | SOLE DISPOSITIVE POWER
- 0 - | |||||
| 8 | SHARED DISPOSITIVE POWER
7,017,385 | |||||
| 9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
7,017,385 | |||||
| 10 | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
☐ | |||||
| 11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
8.0%* | |||||
| 12 | TYPE OF REPORTING PERSON
CO | |||||
| * | Calculated based on the number in Row 9 above divided by 88,116,173, being the total number of Class A Ordinary Shares outstanding as of June 30, 2022, according to the Form 424B5 filed by the Issuer with the Securities and Exchange Commission on November 7, 2022. |
| CUSIP No. G17173 108 | 13G | Page 3 of 14 |
| 1 | NAME OF REPORTING PERSON
CMB International Capital Holdings Corporation Limited | |||||
| 2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ☐ (b) ☐
| |||||
| 3 | SEC USE ONLY
| |||||
| 4 | CITIZENSHIP OR PLACE OF ORGANIZATION
Hong Kong | |||||
| NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH: | 5 | SOLE VOTING POWER
- 0 - | ||||
| 6 | SHARED VOTING POWER
7,017,385 | |||||
| 7 | SOLE DISPOSITIVE POWER
- 0 - | |||||
| 8 | SHARED DISPOSITIVE POWER
7,017,385 | |||||
| 9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
7,017,385 | |||||
| 10 | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
☐ | |||||
| 11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
8.0%* | |||||
| 12 | TYPE OF REPORTING PERSON
CO | |||||
| * | Calculated based on the number in Row 9 above divided by 88,116,173, being the total number of Class A Ordinary Shares outstanding as of June 30, 2022, according to the Form 424B5 filed by the Issuer with the Securities and Exchange Commission on November 7, 2022. |
| CUSIP No. G17173 108 | 13G | Page 4 of 14 |
| 1 | NAME OF REPORTING PERSON
CMB International Capital Corporation Limited | |||||
| 2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ☐ (b) ☐
| |||||
| 3 | SEC USE ONLY
| |||||
| 4 | CITIZENSHIP OR PLACE OF ORGANIZATION
Hong Kong | |||||
| NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH: | 5 | SOLE VOTING POWER
- 0 - | ||||
| 6 | SHARED VOTING POWER
7,017,385 | |||||
| 7 | SOLE DISPOSITIVE POWER
- 0 - | |||||
| 8 | SHARED DISPOSITIVE POWER
7,017,385 | |||||
| 9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
7,017,385 | |||||
| 10 | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
☐ | |||||
| 11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
8.0%* | |||||
| 12 | TYPE OF REPORTING PERSON
CO | |||||
| * | Calculated based on the number in Row 9 above divided by 88,116,173, being the total number of Class A Ordinary Shares outstanding as of June 30, 2022, according to the Form 20-F filed by the Issuer with the Securities and Exchange Commission on November 7, 2022. |
| CUSIP No. G17173 108 | 13G | Page 5 of 14 |
| 1 | NAME OF REPORTING PERSON
CMB International Investment Management Limited | |||||
| 2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ☐ (b) ☐
| |||||
| 3 | SEC USE ONLY
| |||||
| 4 | CITIZENSHIP OR PLACE OF ORGANIZATION
British Virgin Islands | |||||
| NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH: | 5 | SOLE VOTING POWER
- 0 - | ||||
| 6 | SHARED VOTING POWER
7,017,385 | |||||
| 7 | SOLE DISPOSITIVE POWER
- 0 - | |||||
| 8 | SHARED DISPOSITIVE POWER
7,017,385 | |||||
| 9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
7,017,385 | |||||
| 10 | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
☐ | |||||
| 11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
8.0%* | |||||
| 12 | TYPE OF REPORTING PERSON
CO | |||||
| * | Calculated based on the number in Row 9 above divided by 88,116,173, being the total number of Class A Ordinary Shares outstanding as of June 30, 2022, according to the Form 424B5 filed by the Issuer with the Securities and Exchange Commission on November 7, 2022. |
| CUSIP No. G17173 108 | 13G | Page 6 of 14 |
| 1 | NAME OF REPORTING PERSON
CMB International Private Investment Limited | |||||
| 2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ☐ (b) ☐
| |||||
| 3 | SEC USE ONLY
| |||||
| 4 | CITIZENSHIP OR PLACE OF ORGANIZATION
Cayman Islands | |||||
| NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH: | 5 | SOLE VOTING POWER
- 0 - | ||||
| 6 | SHARED VOTING POWER
7,017,385 | |||||
| 7 | SOLE DISPOSITIVE POWER
- 0 - | |||||
| 8 | SHARED DISPOSITIVE POWER
7,017,385 | |||||
| 9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
7,017,385 | |||||
| 10 | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
☐ | |||||
| 11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
8.0%* | |||||
| 12 | TYPE OF REPORTING PERSON
CO | |||||
| * | Calculated based on the number in Row 9 above divided by 88,116,173, being the total number of Class A Ordinary Shares outstanding as of June 30, 2022, according to the Form 424B5 filed by the Issuer with the Securities and Exchange Commission on November 7, 2022. |
| CUSIP No. G17173 108 | 13G | Page 7 of 14 |
| 1 | NAME OF REPORTING PERSONS
EverGreen SeriesC Limited Partnership | |||||
| 2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ☐ (b) ☐
| |||||
| 3 | SEC USE ONLY
| |||||
| 4 | CITIZENSHIP OR PLACE OF ORGANIZATION
Cayman Islands | |||||
| NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH: | 5 | SOLE VOTING POWER
- 0 - | ||||
| 6 | SHARED VOTING POWER
5,964,435 | |||||
| 7 | SOLE DISPOSITIVE POWER
- 0 - | |||||
| 8 | SHARED DISPOSITIVE POWER
5,964,435 | |||||
| 9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
5,964,435 | |||||
| 10 | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
☐ | |||||
| 11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
6.8%* | |||||
| 12 | TYPE OF REPORTING PERSON
PN | |||||
| * | Calculated based on the number in Row 9 above divided by 88,116,173, being the total number of Class A Ordinary Shares outstanding as of June 30, 2022, according to the Form 424B5 filed by the Issuer with the Securities and Exchange Commission on November 7, 2022. |
| CUSIP No. G17173 108 | 13G | Page 8 of 14 |
| 1 | NAME OF REPORTING PERSONS
CMBI Private Equity Series SPC on behalf of and for the account of Biotechnology Fund IV SP | |||||
| 2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ☐ (b) ☐
| |||||
| 3 | SEC USE ONLY
| |||||
| 4 | CITIZENSHIP OR PLACE OF ORGANIZATION
Cayman Islands | |||||
| NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH: | 5 | SOLE VOTING POWER
- 0 - | ||||
| 6 | SHARED VOTING POWER
1,052,950 | |||||
| 7 | SOLE DISPOSITIVE POWER
- 0 - | |||||
| 8 | SHARED DISPOSITIVE POWER
1,052,950 | |||||
| 9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,052,950 | |||||
| 10 | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
☐ | |||||
| 11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
1.2%* | |||||
| 12 | TYPE OF REPORTING PERSON
CO | |||||
| * | Calculated based on the number in Row 9 above divided by 88,116,173, being the total number of Class A Ordinary Shares outstanding as of June 30, 2022, according to the Form 424B5 filed by the Issuer with the Securities and Exchange Commission on November 7, 2022. |
| Item 1(a). | Name of Issuer: |
Burning Rock Biotech Limited
| Item 1(b). | Address of Issuers Principal Executive Offices: |
No. 5, Xingdao Ring Road North
International Bio Island, Guangzhou, 510005
Peoples Republic of China
| Item 2(a). | Name of Person Filing: |
China Merchants Bank Co., Limited
CMB International Capital Holdings Corporation Limited
CMB International Capital Corporation Limited
CMB International Investment Management Limited
CMB International Private Investment Limited
EverGreen SeriesC Limited Partnership
CMBI Private Equity Series SPC on behalf of and for the account of Biotechnology Fund IV SP
(each, a Reporting Person and, collectively, Reporting Persons)
| Item 2(b). | Address of Principal Business Office or, if none, Residence: |
The principal business address of each of the Reporting Persons is as follows:
c/o CMB International Capital Corporation Limited
46th Floor, Champion Tower, 3 Garden Road, Hong Kong
| Item 2(c). | Citizenship: |
Hong Kong:
China Merchants Bank Co., Limited
CMB International Capital Holdings Corporation Limited
CMB International Capital Corporation Limited
British Virgin Islands:
CMB International Investment Management Limited
Cayman Islands:
CMB International Private Investment Limited
EverGreen SeriesC Limited Partnership
CMBI Private Equity Series SPC on behalf of and for the account of
Biotechnology Fund IV SP
| Item 2(d). | Titles of Classes of Securities: |
Class A Ordinary Shares, par value US$0.0002 per share
Page 9 of 14
| Item 2(e). | CUSIP Number: |
G17173 108*
| * | This CUSIP number applies to the Class A Ordinary Shares of the Issuer. CUSIP number 12233L 107 applies to the ADSs of the Issuer, each ADS representing one Class A Ordinary Share. |
| Item 3. | If This Statement is Filed Pursuant to Rule 13d-1(b), or 13d-2(b) or (c), Check Whether the Person Filing is a(n): |
| (a) | ☐ Broker or dealer registered under Section 15 of the Exchange Act (15 U.S.C. 78o). | |||
| (b) | ☐ Bank as defined in Section 3(a)(6) of the Exchange Act (15 U.S.C. 78c). | |||
| (c) | ☐ Insurance company as defined in Section 3(a)(19) of the Exchange Act (15 U.S.C. 78c). | |||
| (d) | ☐ Investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C 80a-8). | |||
| (e) | ☐ Investment adviser in accordance with §240.13d-1(b)(1)(ii)(E). | |||
| (f) | ☐ Employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F). | |||
| (g) | ☐ Parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G). | |||
| (h) | ☐ Savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (13 U.S.C. 1813). | |||
| (i) | ☐ Church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act (15 U.S.C. 80a-3). | |||
| (j) | ☐ Non-U.S. institution in accordance with §240. 13d-1(b)(1)(ii)(J). | |||
|
| (k) | ☐ Group in accordance with §240.13d-1(b)(1)(ii)(K). | ||
| If filing as a non-U.S. institution in accordance with §240. 13d-1(b)(1)(ii)(J), please specify the type of institution: ______________ | ||||
Page 10 of 14
| Item 4. | Ownership |
The following information with respect to the beneficial ownership of the Issuers Class A Ordinary Shares by each of the Reporting Persons is presented as of December 31, 2022:
| Reporting Person | (a) Amount beneficially owned(1): | (b) Percent of class(2): | (c) Number of shares as to which the person has: | |||||||||||||||||||||
| (i) Sole power to vote or to direct the vote | (ii) Shared power to vote or to direct the vote(1) | (iii) Sole power to dispose or to direct the disposition of | (iv) Shared power to dispose or direct the disposition of(1) | |||||||||||||||||||||
| China Merchants Bank Co., Limited | 7,017,385 | 8.0 | % | 0 | 7,017,385 | 0 | 7,017,385 | |||||||||||||||||
| CMB International Capital Holdings Corporation Limited | 7,017,385 | 8.0 | % | 0 | 7,017,385 | 0 | 7,017,385 | |||||||||||||||||
| CMB International Capital Corporation Limited | 7,017,385 | 8.0 | % | 0 | 7,017,385 | 0 | 7,017,385 | |||||||||||||||||
| CMB International Investment Management Limited | 7,017,385 | 8.0 | % | 0 | 7,017,385 | 0 | 7,017,385 | |||||||||||||||||
| CMB International Private Investment Limited | 7,017,385 | 8.0 | % | 0 | 7,017,385 | 0 | 7,017,385 | |||||||||||||||||
| EverGreen SeriesC Limited Partnership | 5,964,435 | 6.8 | % | 0 | 5,964,435 | 0 | 5,964,435 | |||||||||||||||||
| CMBI Private Equity Series SPC on behalf of and for the account of Biotechnology Fund IV SP | 1,052,950 | 1.2 | % | 0 | 1,052,950 | 0 | 1,052,950 | |||||||||||||||||
| (1) | EverGreen SeriesC Limited Partnership (EverGreen), a Cayman Islands exempted limited partnership, directly holds 5,964,435 Class A Ordinary Shares (including 3,829,927 Class A Ordinary Shares in the form of ADSs). CMBI Private Equity Series SPC on behalf of and for the account of Biotechnology Fund IV SP (SPC), a segregated portfolio company incorporated under the laws of the Cayman Islands, directly holds 1,052,950 Class A Ordinary Shares (including 800,000 Class A Ordinary Shares in the form of ADSs). |
CMB International Private Investment Limited (CMBIPI), a company incorporated under the laws of Cayman Islands, is the general partner of EverGreen and owns all the management shares of SPC. CMBIPI is wholly owned by CMB International Investment Management Limited (CMBIIM), a company incorporated under the laws of the British Virgin Islands. CMBIIM is wholly owned by CMB International Capital Corporation Limited (CMBICC), a company incorporated in Hong Kong. CMBICC is a majority owned subsidiary of CMB International Capital Holdings Corporation Limited (CMBICH), a company incorporated in Hong Kong. CMBICH is wholly owned by China Merchants Bank Co., Limited (CMB), a company incorporated in Hong Kong and listed on the Stock Exchange of Hong Kong. Pursuant to Section 13(d) of the Securities Exchange Act of 1934, as amended, and the rules promulgated thereunder, each of CMBIPI, CMBIIM, CMBICC, CMBICH and CMB may be deemed to beneficially own all of the Issuers shares held by EverGreen and SPC.
Page 11 of 14
| (2) | Calculated based on the number of Class A Ordinary Shares beneficially owned by each of the Reporting Persons as of December 31, 2022, divided by 88,116,173, being the total number of Class A Ordinary Shares outstanding as of June 30, 2022, according to the Form 424B5 filed by the Issuer with the Securities and Exchange Commission on November 7, 2022. |
| Item 5. | Ownership of Five Percent or Less of a Class. |
If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following ☐.
| Item 6. | Ownership of More than Five Percent on Behalf of Another Person. |
Not Applicable.
| Item 7. | Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company. |
Not Applicable.
| Item 8. | Identification and Classification of Members of the Group. |
Not Applicable.
| Item 9. | Notice of Dissolution of Group. |
Not Applicable.
| Item 10. | Certification. |
Not Applicable.
Page 12 of 14
Exhibit Index
| Exhibit No. | Description | |
| 99.1 | Joint Filing Agreement | |
Page 13 of 14
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Dated: February 13, 2023
| CHINA MERCHANTS BANK CO., LIMITED | ||
| By: | /s/ Liang Wang | |
| Name: Liang Wang | ||
| Title: Director | ||
| CMB INTERNATIONAL CAPITAL HOLDINGS CORPORATION LIMITED | ||
| By: | /s/ Liang Wang | |
| Name: Liang Wang | ||
| Title: Director | ||
| CMB INTERNATIONAL CAPITAL CORPORATION LIMITED | ||
| By: | /s/ Ju Zhao | |
| Name: Ju Zhao | ||
| Title: Director | ||
| CMB INTERNATIONAL INVESTMENT MANAGEMENT LIMITED | ||
| By: | /s/ Yiwen Gao | |
| Name: Yiwen Gao | ||
| Title: Director | ||
| CMB INTERNATIONAL PRIVATE INVESTMENT LIMITED | ||
| By: | /s/ Rongfeng Jiang | |
| Name: Rongfeng Jiang | ||
| Title: Director | ||
| EVERGREEN SERIESC LIMITED PARTNERSHIP | ||
| By: | CMB International Private Investment Limited, its general partner | |
| By: | /s/ Rongfeng Jiang | |
| Name: Rongfeng Jiang | ||
| Title: Director | ||
| CMBI PRIVATE EQUITY SERIES SPC ON BEHALF OF AND FOR THE ACCOUNT OF BIOTECHNOLOGY FUND IV SP | ||
| By: | /s/ Rongfeng Jiang | |
| Name: Rongfeng Jiang | ||
| Title: Director | ||
Page 14 of 14